Clinical trial
ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy
NCT02773940 · Precision Biopsy, Inc., Industry · Unknown status
Key facts
| NCT number | NCT02773940 |
|---|---|
| Title | ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy |
| Official title | Prospective, Multi-Center Study of the ClariCore™ Optical Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy For Prostate Tissue Classification Algorithm Development |
| Lead sponsor | Precision Biopsy, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device |
| Interventions | ClariCore System |
| Enrollment | 100 |
| Start date | May 1, 2016 |
| Primary completion | Dec 1, 2019 |
| Completion | Jun 1, 2020 |
| First posted | May 16, 2016 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: